Search
Crinetics Pharmaceuticals Inc
CRNXAdd to Watchlist
35.870USD
+0.120+0.34%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
3.78BMarket Cap
LossP/E TTM
Crinetics Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Crinetics Pharmaceuticals Inc is 8.45, ranking 133 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -6.98, which is -32.95% below the recent high of -4.68 and -134.29% above the recent low of -16.36.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
